The Top-Rated Assistive Devices for Children With Sensory Processing Disorders
[Sponsored] The best assistive devices for children with sensory processing disorders are those that meet…
The Top-Rated Assistive Devices for Children With Sensory Processing Disorders
[Sponsored] The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. The post The Top-Rated Assistive Devices for Children With Sensory Processing Disorders appeared first on MedCity News.
Supporting the Whole Patient: The Psychological Value of Scalp Cooling in Breast Cancer Treatment
If we truly believe in treating the whole patient, we must recognize that survival is not the only measure of success. Preserving a woman’s sense of self, her dignity, her identity, her autonomy is just as essential. The post Supporting the Whole Patient: The Psychological Value of Scalp Cooling in Breast Cancer Treatment appeared first…
Tariffs Are Driving up Premiums for Small Businesses
Some insurers in the ACA’s small group market are citing tariffs, particularly those affecting prescriptions drugs, as a reason for higher-than-expected premium increases.
Regulatory Shift Paves Way for AI-Driven Heart Disease Diagnosis
Now, with the ability to measure coronary inflammation through AI-enhanced CT scans and to more accurately determine a person’s risk of heart attack, we can intervene earlier and more effectively. The post Regulatory Shift Paves Way for AI-Driven Heart Disease Diagnosis appeared first on MedCity News.
The Critical Link: How Supporting Nurse Managers Can Help Nurses — And Improve Healthcare
By supporting managers, healthcare organizations can make the workplace better for nurses. That could not only improve retention but build a pipeline of nurse managers. The post The Critical Link: How Supporting Nurse Managers Can Help Nurses — And Improve Healthcare appeared first on MedCity News.
CMS Phasing Out Medicaid Workforce Initiatives
On July 11, CMS notified states that, going forward, it does not anticipate approving new 1115 demonstration workforce initiatives or extending existing waivers. Such changes may limit states’ abilities to pursue initiatives investing in the Medicaid workforce,
FTC Has Long Said Products Must Back Up Health Claims. A MAHA Lawsuit Would Upend That.
Don’t get Nathan Jones started on xylitol, the active ingredient in his chewing gum, nasal spray, and other products. He’ll talk your ear off about its wondrous powers against tooth decay, as well as its potential to fight covid, heart disease, Alzheimer’s — you name it. For now, Jones, the founder of Xlear, can’t make…
As Measles Exploded, Officials in Texas Looked to CDC Scientists. Under Trump, No One Answered.
As measles surged in Texas early this year, the Trump administration’s actions sowed fear and confusion among CDC scientists that kept them from performing the agency’s most critical function — emergency response — when it mattered most, an investigation from KFF Health News shows. The outbreak soon became the worst the United States has endured…
Rosemarie Day & Me invite you to see Atul Gawande
My friend Rosemarie Day joins me to talk about the Healthcare Leaders for Democracy session coming up on September 4 (Thursday) at 8pm ET 5pm PT. It’s a one hour session with Atul Gawande as the keynote speaker, joined by Don Berwick and John McDonough. It’ll be a fascinating discussion and it’s a fundraiser for…
First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen?
Precigen’s Papzimeos is the first FDA-approved drug for the rare disease recurrent respiratory papillomatosis, or RRP. While this immunotherapy carries blockbuster expectations, Precigen’s financial reports indicate budgetary challenges. The post First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen? appeared first on MedCity News.
